Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

CALL FOR SCIENCE SOLACI-CACI 2021 | New Deadline

New deadline: February 28th, 2021.

As we have already informed, due to the uncertainty generated by the current global health situation, the SOLACI CACI Congress scheduled for February 2021, will be held on August 4 thru 6, 2021 at Buenos Aires Hilton Hotel, in Argentina.

For this reason, the Scientific Committee has decided to extend the reception of new works once again, until February 28th, 2021.

In addition, the +350 works that we have already received were reopened to be edited, so that their authors have the opportunity to update and improve them, if they consider it necessary.

The Call for Science system will be enabled UNTIL FEBRUARY 28th 2021 on our official site.

More information

If you have questions or queries write to cientifico@solaci.org


Reasons to be part of the SOLACI-CACI 2021

  • Opportunity: This year, our annual meeting is offering a unique opportunity: the best works will be considered and assesed for publication in Catheterization and Cardiovascular Interventions (CCI) and Journal of Invasive Cardiology (JIC), two prestigious international PubMed Journals.
  • Professional Development: You shall be sharing your knowledge in the largest and most relevant meeting of interventional cardiologists in Latin America.
  • Networking and International Positioning: The best hemodynamics experts in Latin America have chosen this year to go to SOLACI Congress. Make good use of this opportunity to build fruitful relationships, learn, and share your ideas in a fraternal environment of academic excellence.

Cuenta Regresiva de trabajos

MORE INFORMATION ON THE CONGRESS

SOLACI-CACI 2020 Congress Postponed

Highlights

11th Edition of the ProEducar Fellows Course

Opportunities for the Industry

Venue | discover Buenos Aires Hilton Hotel

 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

SOLACI Presented an Outstanding Scientific Session on Complex Coronary Lesions at EuroPCR 2026

The Latin American Society of Interventional Cardiology (SOLACI) had a prominent participation at EuroPCR 2026 through an institutional scientific session held on May 21...

Relive SOLACI’s participation in the V International Congress of Clinical and Interventional Cardiology in the Dominican Republic

The Latin American Society of Interventional Cardiology actively participated in the “V International Congress of Clinical and Interventional Cardiology”, organized by the Asociación Dominicana...

SOLACI to Participate in EuroPCR 2026 with a Scientific Session Focused on the Management of Complex Coronary Lesions

The Latin American Society of Interventional Cardiology will have a prominent participation at EuroPCR 2026 through an institutional scientific session bringing together renowned international...

The Preliminary Scientific Program for SOLACI & SBHCI 2026 Is Now Available

The SOLACI & SBHCI 2026 Congress is already beginning to take shape with the official release of its Preliminary Scientific Program — a high-impact...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...